Is ZOM or RYLD a better dividend investment in 2026?

ZOM currently yields 2055.50% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: ZOM offers higher current income.

What is the dividend yield difference between ZOM and RYLD?

ZOM has a forward dividend yield of 2055.50% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 2043.36 percentage points.

Home › Compare › ZOM vs RYLD

ZOM vs RYLD: Dividend Comparison 2026

ZOM yields 2055.50% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZOM wins by $12828287194.97M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZOM

● Live price

2055.50%

Share price

$0.10

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$12828287195.01M

Annual income

$11,707,825,857,181,476.00

Full ZOM calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — ZOM vs RYLD

📍 ZOM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZOM	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZOM + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZOM pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZOM

Annual income on $10K today (after 15% tax)

$174,717.37/yr

After 10yr DRIP, annual income (after tax)

$9,951,651,978,604,254.00/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, ZOM beats the other by $9,951,651,978,602,054.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZOM + RYLD for your $10,000?

ZOM: 50%RYLD: 50%

100% RYLD50/50100% ZOM

Portfolio after 10yr

$6414143597.53M

Annual income

$5,853,912,928,592,032.00/yr

Blended yield

91.27%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ZOM right now

ZOM

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-0.0

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZOM buys

RYLD buys

No recent congressional trades found for ZOM or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZOMRYLD

Forward yield	2055.50% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$12828287195.01M ✓	$44.5K
Annual income after 10y	$11,707,825,857,181,476.00 ✓	$2,587.35
Total dividends collected	$12748926998.50M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ZOM vs RYLD ($10,000, DRIP)

Year	ZOM Portfolio	ZOM Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$216,250	$205,549.85	$11,914	$1,213.65	+$204.3K → ZOM
2	$4,385,604	$4,154,217.05	$14,099	$1,351.30	+$4.37M → ZOM
3	$83,429,631	$78,737,034.33	$16,580	$1,494.55	+$83.41M → ZOM
4	$1,489,134,673	$1,399,864,967.60	$19,384	$1,642.61	+$1489.12M → ZOM
5	$24,944,940,636	$23,351,566,535.79	$22,535	$1,794.70	+$24944.92M → ZOM
6	$392,269,666,568	$365,578,580,087.90	$26,063	$1,950.00	+$392269.64M → ZOM
7	$5,792,510,495,062	$5,372,781,951,834.12	$29,995	$2,107.69	+$5792510.47M → ZOM
8	$80,345,661,782,925	$74,147,675,553,208.94	$34,361	$2,266.99	+$80345661.75M → ZOM
9	$1,047,160,128,816,172	$961,190,270,708,442.20	$39,194	$2,427.12	+$1047160128.78M → ZOM
10	$12,828,287,195,014,780	$11,707,825,857,181,476.00	$44,525	$2,587.35	+$12828287194.97M → ZOM

ZOM vs RYLD: Complete Analysis 2026

ZOM — Stock

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Full ZOM Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this ZOM vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZOM vs SCHD ZOM vs JEPI ZOM vs O ZOM vs KO ZOM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.